C07F 9/4434
The ester moiety containing a substituent or a structure which is considered
Official title: {the ester moiety containing a substituent or a structure which is considered as characteristic}
C07F9/4434 (The ester moiety containing a substituent or a structure which is considered) appears on 23 US grants and 10 published applications in this corpus.
Search patents in C07F- Granted patents
- 23
- Published applications
- 10
- Assignees
- 12
- Inventors
- 48
- Latest grant
- 5 Feb 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 10 | 0 |
| 1977 | 2 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Processes and intermediates for preparing anti-HIV agents5 Feb 2019US 10,196,419 B2Gilead Sciences, Inc.
- Processes and intermediates for preparing anti-HIV agents10 Oct 2017US 9,783,567 B2Gilead Sciences, Inc.
- Processes and intermediates for preparing anti-HIV agents29 Mar 2016US 9,296,779 B2Gilead Sciences, Inc.
- Processes and intermediates for preparing anti-HIV Agents24 Mar 2015US 8,987,437 B2Gilead Sciences, Inc.
- Cyanophosphonamides and method for preparation17 Apr 2001US 6,218,563 B1Monsanto Company
- Modulator for promoting binding of butyrophilin 3a1/2a130 Jul 2026US 2026/0216219 A1Unicet Biotech Co. LLC.
- Modulator for promoting binding of butyrophilin 3a1/2a123 Jul 2026US 2026/0207637 A1Unicet Biotech Co. LLC.
- Prodrugs of Thyroid Hormone Analogs, Methods of Making and Methods of Using Thereof5 Sep 2024US 2024/0294561 A1Gannex, LLC
- Processes and intermediates for preparing anti-hiv agents28 Nov 2019US 2019/0359644 A1Gilead Sciences, Inc.
- Processes and intermediates for preparing anti-hiv agents22 Mar 2018US 2018/0079773 A1Gilead Sciences, Inc.
Most cited
By later US patents
- O-(2-Carbisopropoxyphenyl)-thiono-phosphoric (phosphonic) acid ester-amides and ester-imides and insecticidal and acaricidal composition and method4US 3,975,523 ABayer Aktiengesellschaft · 1976
- Processes and intermediates for preparing anti-HIV Agents3US 8,987,437 B2Gilead Sciences, Inc. · 2015
- Processes and intermediates for preparing anti-HIV agents3US 9,296,779 B2Gilead Sciences, Inc. · 2016
- Phosphoroimidophenyl insecticides2US 4,219,547 AStauffer Chemical Company · 1980
- Cyanophosphonamides and method for preparation2US 6,218,563 B1Monsanto Company · 2001